WHITEPAPER - Formulating Custom Viscosity Blends With POLYOX™ Polyethylene Oxide



Excipient variability plays a critical role in pharmaceutical product design. A risk-based, scientific approach to Quality by Design (QbD) is essential to ensure consistent drug performance.
Our latest whitepaper delves into the impact of POLYOX™ PEO (Polyethylene Oxide) on drug release, with a focus on viscosity variations. Discover how blending different POLYOX™ PEO grades enables precise gel strength control, leading to enhanced drug release formulations by reducing trial and error combinations to target a desired viscosity.
Read more to gain key insights into robust drug delivery.
Total Page Views: 144